AIP
OKUR

Ameritas Investment Partners’s OnKure Therapeutics OKUR Stock Holding History

Ameritas Investment Partners’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-80
Closed -$1.33K – 3246
2024
Q1 		$1.33K Hold
80
– – ﹤0.01% 3041
2023
Q4 		$1.28K Hold
80
– – ﹤0.01% 3072
2023
Q3 		$6.08K Hold
80
– – ﹤0.01% 2956
2023
Q2 		$5.24K Buy
+80
New +$6.45K ﹤0.01% 3018
2022
Q2 		– Sell
-49
Closed -$1K – 3266
2022
Q1 		$1K Hold
49
– – ﹤0.01% 3071
2021
Q4 		$4K Hold
49
– – ﹤0.01% 3067
2021
Q3 		$4K Hold
49
– – ﹤0.01% 3055
2021
Q2 		$5K Buy
+49
New +$5.46K ﹤0.01% 3000

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ameritas Investment Partners's OKUR Position: Q2 2024 in Review

Ameritas Investment Partners sold out of OnKure Therapeutics (OKUR) in Q2 2024, closing a stake of 80 shares — an estimated $1.33K sold.

Ameritas Investment Partners first reported a position in OKUR in Q2 2021 and held it in 8 quarters. The position peaked at $6.08K in Q3 2023. 66 funds tracked by Wall St. Rank hold OKUR as of Q2 2024.

  • Ameritas Investment Partners reported no remaining OnKure Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 80 OnKure Therapeutics shares in Q2 2024, an estimated $1.33K.
  • Ameritas Investment Partners first reported a position in OnKure Therapeutics in Q2 2021 and held it in 8 quarters.
  • Ameritas Investment Partners's OnKure Therapeutics position peaked at $6.08K in Q3 2023.
  • 66 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.